TapewireFind a company

person · Reporting owner

Lassiter Wright III

Disclosed activity across 3 companies

Tapewire entity
28629
SEC CIK
0001805909

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
DT Midstream, Inc.DTM · Entity 3411DirectorMay 06, 2022May 10, 2022
Fortive CorpFTV · Entity 3303DirectorSeptember 25, 2026September 28, 2026
QUEST DIAGNOSTICS INCDGX · Entity 2118DirectorJuly 22, 2026July 27, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

DT Midstream, Inc.

Report date May 06, 2022 · Filed May 10, 2022

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect1,795 Reported balance After 2022-05-06 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2022-05-06 · Grant · Acquired 1,795 · Balance 1,795

F1: Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

F2: This restricted stock unit will vest on May 5, 2023, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

F2: This restricted stock unit will vest on May 5, 2023, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.

Fortive Corp

Report date September 25, 2026 · Filed September 28, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect25,766.252 Reported balance After 2026-09-25 transaction · row 1
1 source row

Row 1 · 2026-09-25 · Other · Acquired 5.366 · Balance 25,766.252

F1: Reflects shares acquired through an automatic dividend reinvestment service offered to the Reporting Person by a third party brokerage firm.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects shares acquired through an automatic dividend reinvestment service offered to the Reporting Person by a third party brokerage firm.

QUEST DIAGNOSTICS INC

Report date July 22, 2026 · Filed July 27, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect10,323 Reported balance After 2026-07-22 transaction · row 1
1 source row

Row 1 · 2026-07-22 · Other · Acquired 6 · Balance 10,323

F1: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 25, 2026 Filed Sep 28, 2026 23:08 UTC Fortive Corp FTV · Entity 3303 OtherCommon Stock 5.366 $55.92 $300.04
Disclosure

SEC source: 0001805909-26-000011 · wk-form4_1790636896.xml · nonDerivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,766.252

F1 · shares: Reflects shares acquired through an automatic dividend reinvestment service offered to the Reporting Person by a third party brokerage firm.

Read SEC document
July 22, 2026 Filed Jul 27, 2026 20:33 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 OtherCommon Stock 6 $206.81 $1,240.88
Disclosure

SEC source: 0001022079-26-000080 · wk-form4_1785184383.xml · nonDerivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,323

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

Read SEC document
July 02, 2026 Filed Jul 7, 2026 20:47 UTC Fortive Corp FTV · Entity 3303 OtherCommon Stock 4.136 $62.12 $256.93
Disclosure

SEC source: 0001659166-26-000026 · wk-form4_1783457240.xml · nonDerivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,760.886

F1 · shares: Reflects shares acquired through an automatic dividend reinvestment service offered to the Reporting Person by a third party brokerage firm.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 20:49 UTC Fortive Corp FTV · Entity 3303 GrantCommon Stock 1,925 $59.78 $115,076.50
Disclosure

SEC source: 0001805909-26-000009 · wk-form4_1781210986.xml · nonDerivative · entry 2

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,756.75

F2 · shares: On June 9, 2026, the Issuer granted to the Reporting Person restricted stock units ("Deferral RSUs") of the Issuer in the amount indicated, based on a 20-day average price of $59.78, pursuant to deferral election made by the Reporting Person of $115,000 in annual retainer that would otherwise have been paid in cash. Since the Deferral RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Deferral RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2027 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the third year following the Reporting Person's retirement from the Board of Directors of the Issuer.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 20:49 UTC Fortive Corp FTV · Entity 3303 GrantCommon Stock 3,350 $0.00 $0.00
Disclosure

SEC source: 0001805909-26-000009 · wk-form4_1781210986.xml · nonDerivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,831.75

F1 · shares: On June 9, 2026, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2027 annual meeting of the stockholders, but, based on the election of the Reporting Person, the underlying shares will not be issued until the earlier of the Reporting Person's death or the third year following the Reporting Person's retirement from the Board of Directors of the Issuer.

Read SEC document
May 20, 2026 Filed May 21, 2026 20:54 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 1,142 $0.00 $0.00
Disclosure

SEC source: 0001805909-26-000007 · wk-form4_1779396839.xml · nonDerivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,317

F1 · security: Represents an award of restricted stock units.

F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

Read SEC document
April 20, 2026 Filed Apr 24, 2026 22:23 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 OtherCommon Stock 6 $194.70 $1,168.19
Disclosure

SEC source: 0001022079-26-000046 · wk-form4_1777069413.xml · nonDerivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,063

F1 · security: Represents an award of restricted share units.

F2 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

Read SEC document
March 26, 2026 Filed Mar 30, 2026 21:33 UTC Fortive Corp FTV · Entity 3303 OtherCommon Stock 4.67 $54.98 $256.76
Disclosure

SEC source: 0001805909-26-000004 · wk-form4_1774903300.xml · nonDerivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,481.75

F1 · shares: Reflects shares acquired through an automatic dividend reinvestment service offered to the Reporting Person by a third party brokerage firm.

Read SEC document
January 28, 2026 Filed Feb 20, 2026 22:08 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 OtherCommon Stock 7 $183.51 $1,284.57
Disclosure

SEC source: 0001022079-26-000011 · wk-form4_1771625304.xml · nonDerivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,057

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4.

Read SEC document
December 26, 2025 Filed Dec 30, 2025 23:04 UTC Fortive Corp FTV · Entity 3303 OtherCommon Stock 4.61 $55.69 $256.73
Disclosure

SEC source: 0001805909-25-000003 · wk-form4_1767135891.xml · nonDerivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,477.08

F1 · shares: Reflects shares acquired through an automatic dividend reinvestment service offered to the Reporting Person by a third party brokerage firm.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 20:32 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantPhantom Stock Units · Derivative 157 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001022079-25-000206 · wk-form4_1759523536.xml · derivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 678.777

Underlying: Common Stock · 157 shares

Expires not disclosed

F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

F2 · derivative.underlying_shares: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11.

Read SEC document
July 21, 2025 Filed Jul 25, 2025 20:27 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 OtherCommon Stock 7 $167.51 $1,172.54
Disclosure

SEC source: 0001022079-25-000186 · wk-form4_1753475235.xml · nonDerivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,044

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

Read SEC document
July 01, 2025 Filed Jul 2, 2025 20:26 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantPhantom Stock Units · Derivative 160 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001022079-25-000165 · wk-form4_1751487991.xml · derivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 520.854

Underlying: Common Stock · 160 shares

Expires not disclosed

F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

F2 · derivative.underlying_shares: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11.

Read SEC document
June 02, 2025 Filed Jun 5, 2025 00:01 UTC Fortive Corp FTV · Entity 3303 GrantDirector Stock Option (Right to Buy) · Derivative 2,140 $0.00 Strike: $70.26 $0.00
Disclosure

SEC source: 0001659166-25-000084 · wk-form4_1749081677.xml · derivative · entry 3

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,140

Underlying: Common Stock · 2,140 shares

Expires 2035-06-02

Read SEC document
June 02, 2025 Filed Jun 5, 2025 00:01 UTC Fortive Corp FTV · Entity 3303 GrantCommon Stock 1,625 $70.87 $115,163.75
Disclosure

SEC source: 0001659166-25-000084 · wk-form4_1749081677.xml · nonDerivative · entry 2

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,119.884

F2 · shares: On June 2, 2025, the Issuer granted to the Reporting Person restricted stock units ("Deferral RSUs") of the Issuer in the amount indicated, based on a 20-day average price of $70.87, pursuant to deferral election made by the Reporting Person of $115,000 in annual retainer that would otherwise have been paid in cash. Since the Deferral RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Deferral RSUs vest on the earlier of the first anniversary of the grant date or the date of and immediately prior to the Issuer's 2026 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the three-year anniversary of the Reporting Person's retirement from the Board of Directors of the Issuer.

Read SEC document
June 02, 2025 Filed Jun 5, 2025 00:01 UTC Fortive Corp FTV · Entity 3303 GrantCommon Stock 2,120 $0.00 $0.00
Disclosure

SEC source: 0001659166-25-000084 · wk-form4_1749081677.xml · nonDerivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,494.884

F1 · shares: On June 2, 2025, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as a portion of the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of and immediately prior to the Issuer's 2026 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the third anniversary of the Reporting Person's retirement from the Board of Directors of the Issuer.

Read SEC document
May 15, 2025 Filed May 19, 2025 20:21 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 1,203 $0.00 $0.00
Disclosure

SEC source: 0001022079-25-000144 · wk-form4_1747686084.xml · nonDerivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,037

F1 · security: Represents an award of restricted stock units.

Read SEC document
April 01, 2025 Filed Apr 3, 2025 20:40 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantPhantom Stock Units · Derivative 169 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001022079-25-000105 · wk-form4_1743712825.xml · derivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 359.911

Underlying: Common Stock · 169 shares

Expires not disclosed

F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11.

Read SEC document
March 27, 2025 Filed Apr 1, 2025 00:10 UTC Fortive Corp FTV · Entity 3303 GrantCommon Stock 2.451 $74.82 $183.39
Disclosure

SEC source: 0001659166-25-000063 · wk-form4_1743466224.xml · nonDerivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,374.884

F1 · shares: Reflects shares acquired through an automatic dividend reinvestment service offered to the Reporting Person by a third party brokerage firm.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 21:48 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantPhantom Stock Units · Derivative 190 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001022079-25-000003 · wk-form4_1736200076.xml · derivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 190

Underlying: Common Stock · 190 shares

Expires not disclosed

F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

Read SEC document
December 26, 2024 Filed Dec 30, 2024 22:07 UTC Fortive Corp FTV · Entity 3303 GrantCommon Stock 2.433 $75.30 $183.20
Disclosure

SEC source: 0001659166-24-000171 · wk-form4_1735596433.xml · nonDerivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,372.433

F1 · shares: Reflects shares acquired through an automatic dividend reinvestment service offered to the Reporting Person by a third party brokerage firm.

Read SEC document
June 03, 2024 Filed Jun 6, 2024 00:11 UTC Fortive Corp FTV · Entity 3303 GrantDirector Stock Option (Right to Buy) · Derivative 1,990 $0.00 Strike: $72.95 $0.00
Disclosure

SEC source: 0001659166-24-000127 · wk-form4_1717632678.xml · derivative · entry 3

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,990

Underlying: Common Stock · 1,990 shares

Expires 2034-06-03

Read SEC document
June 03, 2024 Filed Jun 6, 2024 00:11 UTC Fortive Corp FTV · Entity 3303 GrantCommon Stock 1,515 $76.14 $115,352.10
Disclosure

SEC source: 0001659166-24-000127 · wk-form4_1717632678.xml · nonDerivative · entry 2

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,370

F2 · shares: On June 3, 2024, the Issuer granted to the Reporting Person restricted stock units ("Deferral RSUs") of the Issuer in the amount indicated, based on a 20-day average price of $76.14, pursuant to deferral election made by the Reporting Person of $115,000 in annual retainer that would otherwise have been paid in cash. Since the Deferral RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Deferral RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2025 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the Issuer.

Read SEC document
June 03, 2024 Filed Jun 6, 2024 00:11 UTC Fortive Corp FTV · Entity 3303 GrantCommon Stock 1,970 $0.00 $0.00
Disclosure

SEC source: 0001659166-24-000127 · wk-form4_1717632678.xml · nonDerivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,855

F1 · shares: On June 3, 2024, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as a portion of the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2025 annual meeting of the stockholders, with the underlying shares to be delivered upon vesting.

Read SEC document
May 16, 2024 Filed May 20, 2024 23:17 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 1,482 $0.00 $0.00
Disclosure

SEC source: 0001022079-24-000119 · wk-form4_1716247063.xml · nonDerivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,709

F1 · shares: Represents an award of restricted share units.

F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 21:43 UTC Fortive Corp FTV · Entity 3303 GrantDirector Stock Option (Right to Buy) · Derivative 2,310 $0.00 Strike: $67.23 $0.00
Disclosure

SEC source: 0001659166-23-000158 · wk-form4_1686260576.xml · derivative · entry 3

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,310

Underlying: Common Stock · 2,310 shares

Expires 2033-06-06

Read SEC document
June 06, 2023 Filed Jun 8, 2023 21:43 UTC Fortive Corp FTV · Entity 3303 GrantCommon Stock 1,755 $65.60 $115,128.00
Disclosure

SEC source: 0001659166-23-000158 · wk-form4_1686260576.xml · nonDerivative · entry 2

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,885

F2 · shares: On June 6, 2023, the Issuer granted to the Reporting Person restricted stock units ("Deferral RSUs") of the Issuer in the amount indicated, based on a 20-day average price of $65.60, pursuant to deferral election made by the Reporting Person of $115,000 in annual retainer that would otherwise have been paid in cash. Since the Deferral RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Deferral RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2024 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the Issuer.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 21:43 UTC Fortive Corp FTV · Entity 3303 GrantCommon Stock 2,290 $0.00 $0.00
Disclosure

SEC source: 0001659166-23-000158 · wk-form4_1686260576.xml · nonDerivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,130

F1 · shares: On June 6, 2023, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as a portion of the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2024 annual meeting of the stockholders, with the underlying shares to be delivered upon vesting.

Read SEC document
May 17, 2023 Filed May 19, 2023 22:21 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 1,369 $0.00 $0.00
Disclosure

SEC source: 0001022079-23-000115 · wk-form4_1684534851.xml · nonDerivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,092

F1 · security: Represents an award of restricted share units.

F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 20:25 UTC Fortive Corp FTV · Entity 3303 GrantDirector Stock Option (Right to Buy) · Derivative 4,570 $0.00 Strike: $63.00 $0.00
Disclosure

SEC source: 0001659166-22-000117 · wf-form4_165471990838406.xml · derivative · entry 3

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,570

Underlying: Common Stock · 4,570 shares

Expires 2032-06-06

Read SEC document
June 06, 2022 Filed Jun 8, 2022 20:25 UTC Fortive Corp FTV · Entity 3303 GrantCommon Stock 1,930 $59.74 $115,298.20
Disclosure

SEC source: 0001659166-22-000117 · wf-form4_165471990838406.xml · nonDerivative · entry 2

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,840

F2 · shares: On June 6, 2022, the Issuer granted to the Reporting Person restricted stock units ("Deferral RSUs") of the Issuer in the amount indicated, based on a 20-day average price of $59.74, pursuant to deferral election made by the Reporting Person of $115,000 in annual retainer that would otherwise have been paid in cash. Since the Deferral RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Deferral RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2023 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the Issuer.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 20:25 UTC Fortive Corp FTV · Entity 3303 GrantCommon Stock 1,510 $0.00 $0.00
Disclosure

SEC source: 0001659166-22-000117 · wf-form4_165471990838406.xml · nonDerivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,910

F1 · shares: On June 6, 2022, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as portion of the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2023 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the Issuer.

Read SEC document
May 18, 2022 Filed May 20, 2022 20:26 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 1,292 $0.00 $0.00
Disclosure

SEC source: 0001022079-22-000089 · wf-form4_165307839400151.xml · nonDerivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,633

F1 · security: Represents an award of restricted share units.

F2 · balance_after: The amount includes approximately 60 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

Read SEC document
May 06, 2022 Filed May 10, 2022 21:54 UTC DT Midstream, Inc. DTM · Entity 3411 GrantRestricted Stock Units · Derivative 1,795 $0.00 $0.00
Disclosure

SEC source: 0000947871-22-000535 · ownership.xml · derivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,795

Underlying: Common Stock · 1,795 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

F2 · derivative.exercise_date: This restricted stock unit will vest on May 5, 2023, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.

F2 · derivative.expiration_date: This restricted stock unit will vest on May 5, 2023, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.

Read SEC document
January 24, 2022 Filed Jan 26, 2022 21:34 UTC Fortive Corp FTV · Entity 3303 GrantEmployee Stock Option (Right to Buy) · Derivative 1,860 $71.96 Strike: $71.96 $133,845.60
Disclosure

SEC source: 0001659166-22-000006 · wf-form4_164323285688097.xml · derivative · entry 3

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,860

Underlying: Common Stock · 1,860 shares

Expires 2032-01-24

Read SEC document
January 24, 2022 Filed Jan 26, 2022 21:34 UTC Fortive Corp FTV · Entity 3303 GrantCommon Stock 785 $73.43 $57,642.55
Disclosure

SEC source: 0001659166-22-000006 · wf-form4_164323285688097.xml · nonDerivative · entry 2

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,400

F3 · shares: On January 24, 2022, the Issuer granted to the Reporting Person restricted stock units ("Deferral RSUs") of the Issuer in the amount indicated, based on a 20-day average price of $73.43, pursuant to deferral election made by the Reporting Person of $57,500 in prorated annual retainer that would otherwise have been paid in cash. Since the Deferral RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Deferral RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2022 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the Issuer.

Read SEC document
January 24, 2022 Filed Jan 26, 2022 21:34 UTC Fortive Corp FTV · Entity 3303 GrantCommon Stock 615 $0.00 $0.00
Disclosure

SEC source: 0001659166-22-000006 · wf-form4_164323285688097.xml · nonDerivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 615

F1 · shares: On January 24, 2022, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as prorated portion of the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2022 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the Issuer.

F2 · price: RSUs are payable in shares of common stock on a one-to-one basis.

Read SEC document
August 02, 2021 Filed Aug 3, 2021 21:30 UTC DT Midstream, Inc. DTM · Entity 3411 GrantRestricted Stock Units · Derivative 2,417 $0.00 $0.00
Disclosure

SEC source: 0000947871-21-000854 · ownership.xml · derivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,417

Underlying: Common Stock · 2,417 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: This restricted stock unit will vest 25% on August 2, 2023, 25% on August 2, 2024 and 50% on August 2, 2025, subject to the Reporting Persons' continued service with the Issuer through the applicable vesting date.

F2 · derivative.expiration_date: This restricted stock unit will vest 25% on August 2, 2023, 25% on August 2, 2024 and 50% on August 2, 2025, subject to the Reporting Persons' continued service with the Issuer through the applicable vesting date.

Read SEC document
May 25, 2021 Filed May 25, 2021 20:44 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 1,363 $0.00 $0.00
Disclosure

SEC source: 0001022079-21-000093 · wf-form4_162197542300450.xml · nonDerivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,281

F1 · security: Represents an award of restricted share units.

F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

Read SEC document
May 19, 2020 Filed May 21, 2020 20:45 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 1,531 $0.00 $0.00
Disclosure

SEC source: 0001022079-20-000129 · wf-form4_159009393260707.xml · nonDerivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,882

F1 · security: Represents an award of restricted share units.

Read SEC document
March 12, 2020 Filed Mar 16, 2020 20:55 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 351 $0.00 $0.00
Disclosure

SEC source: 0001022079-20-000087 · wf-form4_158439209905299.xml · nonDerivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 351

F1 · security: Represents an award of restricted share units.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.